ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation. [electronic resource]
Publication details: Oncotarget Mar 2019Description: 1874-1886 p. digitalISSN:- 1949-2553
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.